100 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page
of 2
KCNK1 Potassium channel, two pore domain subfamily K, member 1 Predicted membrane proteins Voltage-gated ion channels Vesicles Mixed
KCNK13 Potassium channel, two pore domain subfamily K, member 13 Predicted membrane proteins Voltage-gated ion channels Nuclear speckles Cell Junctions Tissue enhanced
KCNK15 Potassium channel, two pore domain subfamily K, member 15 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNK18 Potassium channel, two pore domain subfamily K, member 18 Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels Not detected
KCNK2 Potassium channel, two pore domain subfamily K, member 2 FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels Mitochondria Cytosol Tissue enhanced
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleus Tissue enhanced
KCNK6 Potassium channel, two pore domain subfamily K, member 6 Predicted membrane proteins Transporters Voltage-gated ion channels Plasma membrane Actin filaments Cytosol Mixed
KCNK7 Potassium channel, two pore domain subfamily K, member 7 Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Voltage-gated ion channels Plasma membrane Tissue enriched
KCNMA1 Potassium channel, calcium activated large conductance subfamily M alpha, member 1 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Tissue enhanced
KCNN1 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Actin filaments Cytosol Tissue enriched
KCNN2 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Cytosol Tissue enhanced
KCNN3 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 Predicted membrane proteins Voltage-gated ion channels Nucleoplasm Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Endoplasmic reticulum Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Mixed
KCNQ5 Potassium channel, voltage gated KQT-like subfamily Q, member 5 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Vesicles Tissue enhanced
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Golgi apparatus Plasma membrane Cytosol Tissue enhanced
KCNT1 Potassium channel, sodium activated subfamily T, member 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
KCNT2 Potassium channel, sodium activated subfamily T, member 2 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Tissue enhanced
KCNV2 Potassium channel, voltage gated modifier subfamily V, member 2 Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels Tissue enriched
MCOLN1 Mucolipin 1 Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Plasma membrane Cytosol Expressed in all
MCOLN2 Mucolipin 2 Predicted membrane proteins Transporters Voltage-gated ion channels Intermediate filaments Mixed
MCOLN3 Mucolipin 3 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoli Cytosol Tissue enhanced
PKD2 Polycystic kidney disease 2 (autosomal dominant) Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Endoplasmic reticulum Expressed in all
PKD2L1 Polycystic kidney disease 2-like 1 Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
PKD2L2 Polycystic kidney disease 2-like 2 Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Plasma membrane Cytosol Tissue enriched
SCN11A Sodium channel, voltage gated, type XI alpha subunit Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
SCN1A Sodium channel, voltage gated, type I alpha subunit Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Nuclear bodies Plasma membrane Tissue enhanced
SCN2A Sodium channel, voltage gated, type II alpha subunit Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enriched
SCN3A Sodium channel, voltage gated, type III alpha subunit FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels Tissue enriched
SCN4A Sodium channel, voltage gated, type IV alpha subunit Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Microtubule organizing center Group enriched
SCN8A Sodium channel, voltage gated, type VIII alpha subunit Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Cell Junctions Tissue enriched
SCN9A Sodium channel, voltage gated, type IX alpha subunit Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Plasma membrane Actin filaments Focal adhesion sites Tissue enhanced
TPCN1 Two pore segment channel 1 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Expressed in all
TPCN2 Two pore segment channel 2 Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoli Mixed
TRPA1 Transient receptor potential cation channel, subfamily A, member 1 Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
TRPC1 Transient receptor potential cation channel, subfamily C, member 1 Predicted membrane proteins Transporters Voltage-gated ion channels Vesicles Mixed
TRPC3 Transient receptor potential cation channel, subfamily C, member 3 Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
TRPC6 Transient receptor potential cation channel, subfamily C, member 6 Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Cytosol Tissue enhanced
TRPC7 Transient receptor potential cation channel, subfamily C, member 7 Predicted membrane proteins Voltage-gated ion channels Actin filaments Focal adhesion sites Not detected
TRPM1 Transient receptor potential cation channel, subfamily M, member 1 Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels Nucleoplasm Cytosol Group enriched
TRPM4 Transient receptor potential cation channel, subfamily M, member 4 Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Plasma membrane Mixed
TRPM5 Transient receptor potential cation channel, subfamily M, member 5 Predicted membrane proteins Transporters Voltage-gated ion channels Group enriched
TRPM7 Transient receptor potential cation channel, subfamily M, member 7 Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Nucleoplasm Tissue enriched
TRPV4 Transient receptor potential cation channel, subfamily V, member 4 Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels Mixed
TRPV5 Transient receptor potential cation channel, subfamily V, member 5 Predicted membrane proteins Transporters Voltage-gated ion channels Not detected
TRPV6 Transient receptor potential cation channel, subfamily V, member 6 Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels Tissue enhanced
« prev | Page
of 2